Bifidobacterium and the intestinal mucus layer

Abstract

Bifidobacterium species are integral members of the human gut microbiota and these microbes have significant interactions with the intestinal mucus layer. This review delves into Bifidobacterium-mucus dynamics, shedding light on the multifaceted nature of this relationship. We cover conserved features of Bifidobacterium-mucus interactions, such as mucus adhesion and positive regulation of goblet cell and mucus production, as well as species and strain-specific attributes of mucus degradation. For each interface, we explore the molecular mechanisms underlying these interactions and their potential implications for human health. Notably, we emphasize the ability of Bifidobacterium species to positively influence the mucus layer, shedding light on its potential as a mucin-builder and a therapeutic agent for diseases associated with disrupted mucus barriers. By elucidating the complex interplay between Bifidobacterium and intestinal mucus, we aim to contribute to a deeper understanding of the gut microbiota-host interface and pave the way for novel therapeutic strategies.

Keywords

Bifidobacterium / mucus / intestine / probiotic

References

[1] Song C,Chen S,Zhang X.Intestinal mucus components and secretion mechanisms: what we do and do not know.Exp Mol Med2023;55:681-91 PMCID:PMC10167328

[2] Corfield AP,Clamp JR,Hoskins LC.Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria.Infect Immun1992;60:3971-8 PMCID:PMC257425

[3] Bell A.Mucosal glycan degradation of the host by the gut microbiota.Glycobiology2021;31:691-6 PMCID:PMC8252862

[4] Tailford LE,Kavanaugh D.Mucin glycan foraging in the human gut microbiome.Front Genet2015;6:81 PMCID:PMC4365749

[5] McGuckin MA,Sutton P.Mucin dynamics and enteric pathogens.Nat Rev Microbiol2011;9:265-78

[6] McDole JR,McDonald KG.Goblet cells deliver luminal antigen to CD103⁺ dendritic cells in the small intestine.Nature2012;483:345-9 PMCID:PMC3313460

[7] Aihara E,Montrose MH.Trefoil factor peptides and gastrointestinal function.Annu Rev Physiol2017;79:357-80 PMCID:PMC5474939

[8] Croucher SC,Bayliss CE.Bacterial populations associated with different regions of the human colon wall.Appl Environ Microbiol1983;45:1025-33 PMCID:PMC242405

[9] Vasapolli R,Schulz C.Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals.Gastroenterology2019;157:1081-92.e3

[10] Turroni F,Foroni E.Microbiomic analysis of the bifidobacterial population in the human distal gut.ISME J2009;3:745-51

[11] Collado MC,Ribes-Koninckx C,Sanz Y.Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease.BMC Microbiol2008;8:232 PMCID:PMC2635381

[12] von Wright A,Llopis MP.The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis.Int Dairy J2002;12:197-200

[13] Ahmed S,Fite A,Gilbert P.Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples.Appl Environ Microbiol2007;73:7435-42 PMCID:PMC2168195

[14] Chassaing B.Identification of inner mucus-associated bacteria by laser capture microdissection.Cell Mol Gastroenterol Hepatol2019;7:157-60 PMCID:PMC6260373

[15] O’Callaghan A.Bifidobacteria and their role as members of the human gut microbiota.Front Microbiol2016;7:925 PMCID:PMC4908950

[16] O’Neill I,Hall LJ.Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases.Emerg Top Life Sci2017;1:333-49 PMCID:PMC7288987

[17] Grimm V,Riedel CU.Bifidobacteria-host interactions - an update on colonisation factors.Biomed Res Int2014;2014:960826 PMCID:PMC4177770

[18] Engevik MA,Chang-Graham AL.Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways.mBio2019;10:e01087-19 PMCID:PMC6581858

[19] Ruas-Madiedo P,Fernández-García M,Margolles A.Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota.Appl Environ Microbiol2008;74:1936-40 PMCID:PMC2268317

[20] Png CW,Gilshenan KS.Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.Am J Gastroenterol2010;105:2420-8

[21] Lugli GA,Turroni F.Comparative genomic and phylogenomic analyses of the bifidobacteriaceae family.BMC Genomics2017;18:568 PMCID:PMC5540593

[22] Lugli GA,Turroni F.Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics.Appl Environ Microbiol2014;80:6383-94 PMCID:PMC4178631

[23] Milani C,Duranti S.Genomics of the genus Bifidobacterium reveals species-specific adaptation to the glycan-rich gut environment.Appl Environ Microbiol2016;82:980-91 PMCID:PMC4751850

[24] Nuriel-Ohayon M,Koren O.Microbial changes during pregnancy, birth, and infancy.Front Microbiol2016;7:1031 PMCID:PMC4943946

[25] Makino H,Ishikawa E.Multilocus sequence typing of bifidobacterial strains from infant’s faeces and human milk: are bifidobacteria being sustainably shared during breastfeeding?.Benef Microbes2015;6:563-72

[26] Newman J.How breast milk protects newborns.Sci Am1995;273:76-9

[27] Arboleya S,Solís G.Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates.Anaerobe2013;19:9-16

[28] Bäckhed F,Peng Y.Dynamics and stabilization of the human gut microbiome during the first year of life.Cell Host Microbe2015;17:690-703

[29] Lim ES,Zhao G.Early life dynamics of the human gut virome and bacterial microbiome in infants.Nat Med2015;21:1228-34 PMCID:PMC4710368

[30] Makino H,Ishikawa E.Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota.PLoS One2013;8:e78331 PMCID:PMC3828338

[31] Turroni F,Pass DA.Diversity of bifidobacteria within the infant gut microbiota.PLoS One2012;7:e36957 PMCID:PMC3350489

[32] Khonsari S,Burczynska B,Choudhury M.A comparative study of bifidobacteria in human babies and adults.Biosci Microb Food H2016;35:97-103 PMCID:PMC4858883

[33] Luk B,Engevik M.Postnatal colonization with human “infant-type” Bifidobacterium species alters behavior of adult gnotobiotic mice.PLoS One2018;13:e0196510 PMCID:PMC5953436

[34] Luck B,Ganesh BP.Bifidobacteria shape host neural circuits during postnatal development by promoting synapse formation and microglial function.Sci Rep2020;10:7737 PMCID:PMC7210968

[35] Kiu R,Harnisch LC.Bifidobacterium breve UCC2003 induces a distinct global transcriptomic program in neonatal murine intestinal epithelial cells.iScience2020;23:101336 PMCID:PMC7371750

[36] Sudo N,Aiba Y.Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice.J Physiol2004;558:263-75 PMCID:PMC1664925

[37] Turroni F,Ventura M.The human gut microbiota during the initial stages of life: insights from bifidobacteria.Curr Opin Biotechnol2022;73:81-7

[38] Taft DH,Maldonado-Gomez MX.Bifidobacterial dominance of the gut in early life and acquisition of antimicrobial resistance.mSphere2018;3:e00441-18 PMCID:PMC6158511

[39] Lin C,Zhang H.Intestinal ‘infant-type’ Bifidobacteria mediate immune system development in the first 1000 days of life.Nutrients2022;14:1498 PMCID:PMC9002861

[40] Mitsuoka T.Taxonomy and ecology of Bifidobacteria.Bifidobacteria Microflora1984;3:11-28

[41] Ouwehand AC,Kirjavainen PV.Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups.FEMS Microbiol Lett1999;172:61-4

[42] Arboleya S,Stanton C.Gut Bifidobacteria populations in human health and aging.Front Microbiol2016;7:1204 PMCID:PMC4990546

[43] Sovran B,Elderman M.Age-associated impairment of the mucus barrier function is associated with profound changes in microbiota and immunity.Sci Rep2019;9:1437 PMCID:PMC6363726

[44] Elderman M,Hugenholtz F.The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice.PLoS One2017;12:e0184274 PMCID:PMC5595324

[45] Saffrey MJ.Aging of the mammalian gastrointestinal tract: a complex organ system.Age2014;36:9603 PMCID:PMC4082571

[46] He F,Hashimoto H,Benno Y.Adhesion of Bifidobacterium spp. to human intestinal mucus.Microbiol Immunol2001;45:259-62

[47] Kirjavainen PV,Isolauri E.The ability of probiotic bacteria to bind to human intestinal mucus.FEMS Microbiol Lett1998;167:185-9

[48] Harata G,Wang R.Species- and age/generation-dependent adherence of Bifidobacterium bifidum to human intestinal mucus in vitro.Microorganisms2021;9:542 PMCID:PMC7998455

[49] Mantziari A,Ouwehand AC.The effect of donor human milk fortification on the adhesion of probiotics in vitro.Nutrients2020;12:182 PMCID:PMC7019708

[50] Juntunen M,Ouwehand AC,Isolauri E.Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.Clin Diagn Lab Immunol2001;8:293-6 PMCID:PMC96052

[51] Ouwehand AC,Salminen SJ.The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro.FEMS Microbiol Lett1999;177:35-8

[52] Collado MC,Sanz Y.Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance.J Food Prot2006;69:1675-9

[53] Kainulainen V,Hiippala K.BopA does not have a major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins, and mucus.Appl Environ Microbiol2013;79:6989-97 PMCID:PMC3811531

[54] Collado MC,Meriluoto J.Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.Asia Pac J Clin Nutr2006;15:570-5

[55] Collado MC,Salminen S.Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?.J Dairy Sci2007;90:2710-6

[56] Gueimonde M,de los Reyes-Gavilán CG.Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile - a preliminary study.Int J Food Microbiol2007;113:228-32

[57] Collado MC,Hernández M,Salminen S.Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion.J Food Prot2005;68:2672-8

[58] Gueimonde M,Margolles A,Salminen S.Ability of Bifidobacterium strains with acquired resistance to bile to adhere to human intestinal mucus.Int J Food Microbiol2005;101:341-6

[59] Engevik MA,Hall A.The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal.BMC Microbiol2021;21:154 PMCID:PMC8145834

[60] los Reyes-Gavilán CG, Suárez A, Fernández-García M, Margolles A, Gueimonde M, Ruas-Madiedo P. Adhesion of bile-adapted Bifidobacterium strains to the HT29-MTX cell line is modified after sequential gastrointestinal challenge simulated in vitro using human gastric and duodenal juices.Res Microbiol2011;162:514-9

[61] Kadlec R.The effect of prebiotics on adherence of probiotics.J Dairy Sci2014;97:1983-90

[62] Bernet MF,Neeser JR.Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions.Appl Environ Microbiol1993;59:4121-8 PMCID:PMC195875

[63] Gandhi A.Effect of salt stress on morphology and membrane composition of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum, and their adhesion to human intestinal epithelial-like Caco-2 cells.J Dairy Sci2016;99:2594-605

[64] Laparra JM.Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium.Lett Appl Microbiol2009;49:695-701

[65] Aissi EA,Brassart C.Adhesion of some Bifidobacterial strains to human enterocyte-like cells and binding to mucosal glycoproteins.Microb Ecol Health Dis2001;13:32-9

[66] Zhang G,Wen R,Liu L.2'-Fucosyllactose promotes Bifidobacterium bifidum DNG6 adhesion to Caco-2 cells.J Dairy Sci2020;103:9825-34

[67] Riedel CU,Goldstein DR,Eikmanns BJ.Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles.Int J Food Microbiol2006;110:62-8

[68] Morita H,Fuse T.Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion.Microbiol Immunol2002;46:293-7

[69] Serafini F,Ruas-Madiedo P.Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010.Anaerobe2013;21:9-17

[70] Izquierdo E,Ennahar S,Sanz Y.Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains.Curr Microbiol2008;56:613-8

[71] Collado MC,Salminen S.Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa.Curr Microbiol2007;55:260-5

[72] Macfarlane S,Macfarlane GT.Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system.Appl Environ Microbiol2005;71:7483-92 PMCID:PMC1287682

[73] Klijn A,Arigoni F.Lessons from the genomes of bifidobacteria.FEMS Microbiol Rev2005;29:491-509

[74] Westermann C,Corr SC.A critical evaluation of bifidobacterial adhesion to the host tissue.Front Microbiol2016;7:1220 PMCID:PMC4974247

[75] Xiong Y,Lei Y,Hao Y.A novel major pilin subunit protein fimm is involved in adhesion of Bifidobacterium longum BBMN68 to intestinal epithelial cells.Front Microbiol2020;11:590435 PMCID:PMC7719627

[76] Turroni F,Foroni E.Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions.Proc Natl Acad Sci U S A2013;110:11151-6 PMCID:PMC3703987

[77] Nishiyama K,Sugiyama M.Bifidobacterium bifidum extracellular sialidase enhances adhesion to the mucosal surface and supports carbohydrate assimilation.mBio2017;8:e00928-17 PMCID:PMC5626965

[78] González-Rodríguez I,Ruiz L.Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation.Appl Environ Microbiol2012;78:3992-8 PMCID:PMC3346390

[79] Yuan J,Sun Z.Analysis of host-inducing proteome changes in Bifidobacterium longum NCC2705 grown in vivo.J Proteome Res2008;7:375-85

[80] Schell MA,Snel B.The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract.Proc Natl Acad Sci U S A2002;99:14422-7 PMCID:PMC137899

[81] Wei X,Chen X.Proteomic analysis of the interaction of Bifidobacterium longum NCC2705 with the intestine cells Caco-2 and identification of plasminogen receptors.J Proteomics2014;108:89-98

[82] Candela M,Centanni M.Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host.Microbiology2009;155:3294-303

[83] Sun Y,Zhang QX.The expression of GroEL protein amplified from Bifidobacterium animalis subsp. lactis KLDS 2.0603 and its role in competitive adhesion to Caco-2.Food Biotechnol2016;30:292-305

[84] Shkoporov AN,Kafarskaia LI.Search for protein adhesin gene in Bifidobacterium longum genome using surface phage display technology.Bull Exp Biol Med2008;146:782-5

[85] Suzuki R,Kitaoka M.Crystallographic and mutational analyses of substrate recognition of endo-alpha-N-acetylgalactosaminidase from Bifidobacterium longum.J Biochem2009;146:389-98

[86] Garrido D,German JB,Mills DA.Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans.PLoS One2011;6:e17315 PMCID:PMC3057974

[87] Tam R.Structural, functional, and evolutionary relationships among extracellular solute-binding receptors of bacteria.Microbiol Rev1993;57:320-46 PMCID:PMC372912

[88] O’Connell Motherway M,Leahy SC.Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor.Proc Natl Acad Sci U S A2011;108:11217-22 PMCID:PMC3131351

[89] Nishiyama K,Sugiyama M.Extracellular vesicles produced by Bifidobacterium longum export mucin-binding proteins.Appl Environ Microbiol2020;86:e01464-20 PMCID:PMC7499026

[90] Mantziari A,Collado MC,Gómez-Gallego C.Exogenous polyamines influence in vitro microbial adhesion to human mucus according to the age of mucus donor.Microorganisms2021;9:1239 PMCID:PMC8226599

[91] Tuo Y,Song Y.Screening probiotics from Lactobacillus strains according to their abilities to inhibit pathogen adhesion and induction of pro-inflammatory cytokine IL-8.J Dairy Sci2018;101:4822-9

[92] Monteagudo-Mera A,Gibson GR,Chatzifragkou A.Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health.Appl Microbiol Biotechnol2019;103:6463-72 PMCID:PMC6667406

[93] Klaenhammer TR.Selection and design of probiotics.Int J Food Microbiol1999;50:45-57

[94] Tuomola E,Playne M,Salminen S.Quality assurance criteria for probiotic bacteria.Am J Clin Nutr2001;73:393S-8S

[95] Engevik MA,Visuthranukul C.Human-derived Bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain axis.Cell Mol Gastroenterol Hepatol2021;11:221-48 PMCID:PMC7683275

[96] Engevik MA,Ruan W.Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation.Gut Microbes2021;13:1-21 PMCID:PMC8128206

[97] Fukuda S,Hase K.Bifidobacteria can protect from enteropathogenic infection through production of acetate.Nature2011;469:543-7

[98] Yu JY,Puthiyakunnon S.Mucin2 is required for probiotic agents-mediated blocking effects on meningitic e. coli-induced pathogenicities.J Microbiol Biotechnol2015;25:1751-60

[99] Rivière A,Weckx S,De Vuyst L.Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and eubacterium rectale ATCC 33656 explain the bifidogenic and butyrogenic effects of arabinoxylan oligosaccharides.Appl Environ Microbiol2015;81:7767-81 PMCID:PMC4616955

[100] Bunesova V,Schwab C.Mucin cross-feeding of infant bifidobacteria and eubacterium hallii.Microb Ecol2018;75:228-38

[101] Schwab C,Bunesova V,Beerenwinkel N.Trophic interactions of infant Bifidobacteria and eubacterium hallii during L-Fucose and fucosyllactose degradation.Front Microbiol2017;8:95 PMCID:PMC5277004

[102] Rios-Covian D,Duncan SH,de los Reyes-Gavilan CG.Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.FEMS Microbiol Lett2015;362:fnv176

[103] Glover JS,Engevik MA.Characterizing the mucin-degrading capacity of the human gut microbiota.Sci Rep2022;12:8456 PMCID:PMC9120202

[104] Fang J,Zhou Y,Zhou H.Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.Exp Mol Med2021;53:772-87 PMCID:PMC8178360

[105] Crouch LI,Urbanowicz PA.Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown.Nat Commun2020;11:4017

[106] Raba G.Mucin utilization by gut microbiota: recent advances on characterization of key enzymes.Essays Biochem2023;67:345-53 PMCID:PMC10154618

[107] Marcobal A,Earle KA.A refined palate: bacterial consumption of host glycans in the gut.Glycobiology2013;23:1038-46 PMCID:PMC3724412

[108] Turroni F,Foroni E.Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging.Proc Natl Acad Sci U S A2010;107:19514-9 PMCID:PMC2984195

[109] Ruiz L,Couté Y.Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus.FEMS Microbiol Lett2011;314:125-30

[110] Katayama T,Kimura T.Molecular cloning and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95).J Bacteriol2004;186:4885-93 PMCID:PMC451662

[111] Egan M,Kilcoyne M.Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium.BMC Microbiol2014;14:282 PMCID:PMC4252021

[112] Takada H,Sakanaka M,Katayama T.GH20 and GH84 β-N-acetylglucosaminidases with different linkage specificities underpin mucin O-glycan breakdown capability of Bifidobacterium bifidum.J Biol Chem2023;299:104781 PMCID:PMC10245121

[113] Gibson GR,Wang X.Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin.Gastroenterology1995;108:975-82

[114] Zhou JS,Gill HS.Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.Int J Food Microbiol2001;63:81-90

[115] Subramani DB,Dahlén G.Lactobacillus and Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon mucus.Benef Microbes2010;1:343-50

[116] Derrien M,van de Bovenkamp JH,de Vos WM.Mucin-bacterial interactions in the human oral cavity and digestive tract.Gut Microbes2010;1:254-68 PMCID:PMC3023607

[117] Norin KE,Lindblad BS.The establishment of some microflora associated biochemical characteristics in feces from children during the first years of life.Acta Paediatr Scand1985;74:207-12

[118] Midtvedt AC,Midtvedt T.Establishment of a mucin-degrading intestinal microflora during the first two years of human life.J Pediatr Gastroenterol Nutr1994;18:321-6

[119] Karav S,Frese SA.Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001.FEBS Open Bio2018;8:1649-57 PMCID:PMC6168692

[120] Klaassens ES,Haarman M.Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants.Appl Environ Microbiol2009;75:2668-76 PMCID:PMC2681671

[121] Belzer C.Nutritional strategies for mucosal health: the interplay between microbes and mucin glycans.Trends Microbiol2022;30:13-21

[122] Desai MS,Koropatkin NM.A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility.Cell2016;167:1339-53.e21 PMCID:PMC5131798

[123] Schroeder BO,Ståhlman M.Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration.Cell Host Microbe2018;23:27-40.e7 PMCID:PMC5764785

[124] Yoshihara T,Kato T.The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin.Gut Microbes2020;11:1385-404 PMCID:PMC7527075

[125] Mangin I,Lévêque C.Oral administration of viable Bifidobacterium pseudolongum strain patronus modified colonic microbiota and increased mucus layer thickness in rat.FEMS Microbiol Ecol2018;94:fiy177

[126] Caballero-Franco C,De Simone C.The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells.Am J Physiol Gastrointest Liver Physiol2007;292:G315-22

[127] Burger-van Paassen N,Puiman PJ.The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.Biochem J2009;420:211-9

[128] Romond MB,Romond C.Colonization of the Murine Gut by Bifidobacterium bifidum and Clostridium perfringens during ageing.Microb Ecol Health Dis1998;10:91-4

[129] Romond MB,Mielcareck C.Bifidobacteria and human health: regulatory effect of indigenous bifidobacteria on Escherichia coli intestinal colonization.Anaerobe1997;3:131-6

[130] Toumi R,Rafa H.Beneficial role of the probiotic mixture ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.Immunopharmacol Immunotoxicol2013;35:403-9

[131] Crespo I,Prause C.Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis.PLoS One2012;7:e50407 PMCID:PMC3508929

[132] Takagi T,Fujii J.Elevated ER stress exacerbates dextran sulfate sodium-induced colitis in PRDX4-knockout mice.Free Radic Biol Med2019;134:153-64

[133] Ardite E,Panés J,Piqué JM.Replenishment of glutathione levels improves mucosal function in experimental acute colitis.Lab Invest2000;80:735-44

[134] Grisham MB,Tso P.Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species.Gastroenterology1991;101:540-7

[135] Brandl K,Li X.Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response.Proc Natl Acad Sci U S A2009;106:3300-5 PMCID:PMC2651297

[136] Kaser A,Franke A.XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.Cell2008;134:743-56 PMCID:PMC2586148

[137] Heazlewood CK,Eri R.Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.PLoS Med2008;5:e54 PMCID:PMC2270292

[138] Zhao F,Dizon D.Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice.Dev Biol2010;338:270-9 PMCID:PMC2937056

[139] Bertolotti A,Novoa I.Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice.J Clin Invest2001;107:585-93 PMCID:PMC199427

[140] Cao SS.Epithelial ER stress in Crohn’s disease and ulcerative colitis.Inflamm Bowel Dis2016;22:984-93

[141] Cao SS,Chuang BM.The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice.Gastroenterology2013;144:989-1000.e6 PMCID:PMC3751190

[142] Akiyama T,Wullaert A.Bifidobacteria prevent tunicamycin-induced endoplasmic reticulum stress and subsequent barrier disruption in human intestinal epithelial Caco-2 monolayers.PLoS One2016;11:e0162448 PMCID:PMC5017626

[143] Allen J.Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers.J Altern Complement Med2011;17:827-33 PMCID:PMC3162377

[144] Chakravarthi S,Bulleid NJ.The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress.EMBO Rep2006;7:271-5 PMCID:PMC1456887

[145] Holmes EW,Eiznhamer D.Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis.Dig Dis Sci1998;43:1088-95

[146] Hwang C,Lodish HF.Oxidized redox state of glutathione in the endoplasmic reticulum.Science1992;257:1496-502

[147] Quintana-Cabrera R,Bobo-Jimenez V.γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor.Nat Commun2012;3:718 PMCID:PMC3316877

[148] Hasnain SZ,Das I.IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells.Gastroenterology2013;144:357-68.e9

[149] Van der Sluis M,De Bruijn AC.Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.Gastroenterology2006;131:117-29

[150] Tadesse S,Dhima E.MUC2 mucin deficiency alters inflammatory and metabolic pathways in the mouse intestinal mucosa.Oncotarget2017;8:71456-70 PMCID:PMC5641062

[151] Bergstrom K,Johansson MEV.Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.Mucosal Immunol2017;10:91-103 PMCID:PMC5097036

[152] Maurel M,Avril T.Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation.EMBO Mol Med2019;11:e10120 PMCID:PMC6554669

[153] Park SW,Verhaeghe C.The protein disulfide isomerase AGR2 is essential for production of intestinal mucus.Proc Natl Acad Sci U S A2009;106:6950-5 PMCID:PMC2678445

[154] Trabucchi E,Baratti C,Fregoni F.Differential diagnosis of Crohn’s disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope.Int J Tissue React1986;8:79-84

[155] Hanski C,Foss HD.Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn’s disease increases detectability of the MUC2 protein core. J Pathol 1999;188:304-11.

[156] Wenzel UA,Rydström A.Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.PLoS One2014;9:e100217 PMCID:PMC4063762

[157] Tytgat KM,Einerhand AW,Dekker J.Quantitative analysis of MUC2 synthesis in ulcerative colitis.Biochem Biophys Res Commun1996;224:397-405

[158] Pullan RD,Rhodes M.Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.Gut1994;35:353-9 PMCID:PMC1374589

[159] Raouf AH,Parker N,Walker RJ.Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis.Clin Sci1992;83:623-6

[160] Larsson JM,Crespo JG.Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation.Inflamm Bowel Dis2011;17:2299-307

[161] Antoni L,Wehkamp J.Intestinal barrier in inflammatory bowel disease.World J Gastroenterol2014;20:1165-79 PMCID:PMC3921501

[162] Johansson ME,Holmén-Larsson J.Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.Gut2014;63:281-91 PMCID:PMC3740207

[163] Zhang K.From endoplasmic-reticulum stress to the inflammatory response.Nature2008;454:455-62 PMCID:PMC2727659

[164] Shkoda A,Daniel H.Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.Gastroenterology2007;132:190-207

[165] Eri RD,Tran TV.An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity.Mucosal Immunol2011;4:354-64 PMCID:PMC3130192

[166] Cui QY,Liang X.Bifidobacterium bifidum relieved DSS-induced colitis in mice potentially by activating the aryl hydrocarbon receptor.Food Funct2022;13:5115-23

[167] Wang H,Zhao Z,Hao Y.Anti-inflammatory effect of Bifidobacterium animalis subsp. lactis A6 on DSS-induced colitis in mice.J Appl Microbiol2022;133:2063-73

[168] Lee SY,Park JH,Ji GE.Bifidobacterium bifidum BGN4 paraprobiotic supplementation alleviates experimental colitis by maintaining gut barrier and suppressing nuclear factor kappa B activation signaling molecules.J Med Food2022;25:146-57

[169] Yan S,Ross RP.Bifidobacterium longum subsp. longum YS108R fermented milk alleviates DSS induced colitis via anti-inflammation, mucosal barrier maintenance and gut microbiota modulation.J Funct Foods2020;73:104153

[170] Park IS,Yu J.Bifidobacterium breve CBT BR3 is effective at relieving intestinal inflammation by augmenting goblet cell regeneration.J Gastroenterol Hepatol2023;38:1346-54

[171] Singh S,Khare P.Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice.Sci Rep2020;10:18597

[172] Chen Y,Stanton C.Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation.Eur J Nutr2021;60:369-87

[173] Chen Y,Hong G.Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis.Life Sci2020;240:117089

[174] Niu MM,Cai JW.Bifidobacterium breve alleviates DSS-induced colitis in mice by maintaining the mucosal and epithelial barriers and modulating gut microbes.Nutrients2022;14:3671

[175] Zhou L,Xie Y,Li Y.Bifidobacterium infantis induces protective colonic PD-L1 and foxp3 regulatory T cells in an acute murine experimental model of inflammatory bowel disease.Gut Liver2019;13:430-9

[176] Zuo L,Yu L,Chung PC.Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.World J Gastroenterol2014;20:18316-29

[177] Chen M,Dai M,Li C.Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in zebrafish models.PLoS One2022;17:e0262942

[178] Roselli M,Nuccitelli S.Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.Inflamm Bowel Dis2009;15:1526-36

[179] Martín R,Chain F.Bifidobacterium animalis ssp. lactis CNCM-I2494 restores gut barrier permeability in chronically low-grade inflamed mice.Front Microbiol2016;7:608 PMCID:PMC4858658

[180] Yue Y,Xie Q.Bifidobacterium bifidum E3 combined with Bifidobacterium longum subsp. infantis E4 improves LPS-induced intestinal injury by inhibiting the TLR4/NF-κB and MAPK signaling pathways in vivo.J Agric Food Chem2023;71:8915-30

[181] Khailova L,Arganbright KM.Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.Am J Physiol Gastrointest Liver Physiol2009;297:G940-9 PMCID:PMC2777452

[182] Lueschow SR,Frese SA.Bifidobacterium longum subspecies infantis strain EVC001 decreases neonatal murine necrotizing enterocolitis.Nutrients2022;14:495 PMCID:PMC8839161

[183] Bergmann KR,Tian R.Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis.Am J Pathol2013;182:1595-606

[184] Braga TD,de Lira PIC.Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.Am J Clin Nutr2011;93:81-6

[185] Kawahara T,Oikawa Y.Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.PLoS One2017;12:e0173979

[186] Weng M,Zhu W,Walker WA.Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice.Am J Physiol Gastrointest Liver Physiol2014;306:G779-87

[187] Engevik KA,Montrose MH.Organoids as a model to study infectious disease. In: Medina C, López-baena FJ, editors. Host-Pathogen Interactions. New York: Springer; 2018. p. 71-81.

[188] Engevik MA,Engevik KA.Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.Gut Microbes2020;11:1324-47

[189] Engevik MA,Chang-Graham AL.Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis.Am J Physiol Gastrointest Liver Physiol2020;318:G870-88